AZD8566 Food Effect/Microtracer Study

AstraZeneca logo

AstraZeneca

Status and phase

Completed
Phase 1

Conditions

Healthy Volunteer Study

Treatments

Drug: AZD8566 IV carbon labelled
Drug: AZD8566

Study type

Interventional

Funder types

Industry

Identifiers

NCT00866385
D1320C00011
Pharmaceutical Profiles PL1168

Details and patient eligibility

About

A study designed to look at how the drug AZD8566 is taken up by the body when given with or without food. In some subjects a comparison will be made with a very small labelled microdose given into a vein.

Enrollment

21 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Provision of written informed consent
  • Clinically normal physical findings and laboratory values as judged by the investigator with normal ECG
  • Females who are permanently or surgically sterile or post-menopausal and males

Exclusion criteria

  • History of any convulsions or seizures
  • History of infection or risk of infection due to recent surgery or trauma
  • History or presence of conditions know to interfere with the absorption, distribution, metabolism and excretion of the study drug

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems